A former FDA official told jurors this week that Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics followed proper federal guidelines in monitoring its now-recalled metal-on-metal hip implants.

Forder Center for Devices & Radiological Health compliance officer Timothy Ulatowski testified in a patient injury lawsuit against DePuy and its ASR XL implants that the company followed required guidelines for monitoring its hip implants once they hit the market, and that the safety evaluations were "very thorough," Law 360.com reported.

The testimony is among the latest updates from the 2nd DePuy metal hip implant lawsuit to go to trial, which has been a mixed bag for the medical device maker. Earlier this week one of the lead designers of the ASR XL hip told jurors that the devices were properly designed and developed, but noted that he wouldn’t recommend the implant today were it still on the market.

Earlier this month a former DePuy marketing director claimed that internal emails sent more than a year prior to the initial recall of the ASR XL metal hip implants warned that the product might be defective in design.